Literature DB >> 18245663

Survivin overexpression alone does not alter megakaryocyte ploidy nor interfere with erythroid/megakaryocytic lineage development in transgenic mice.

Donald J McCrann1, Todd Yezefski, Hao G Nguyen, Nicholas Papadantonakis, Hui Liu, Qiang Wen, John D Crispino, Katya Ravid.   

Abstract

The level of survivin was reported to be scarce in mouse megakaryocytes (MKs) compared with erythroid cells. Considering this finding and previously reported in vitro data showing decreased MK ploidy upon retroviral-mediated overexpression of survivin, we sought to examine whether ectopic survivin expression in the MK lineage might alter ploidy level in vivo. Here we report the generation of 2 tissue specific hematopoietic transgenic mouse models, one expressing survivin in both the erythroid and MK lineages and the other expressing survivin solely in the MK lineage. Survivin protein overexpression was confirmed in MKs and erythrocytes. Surprisingly, analysis of both transgenic mouse lines showed no detectable changes in MK number, ploidy level, and platelet and erythrocyte counts, as compared with control mice. We conclude that elevated survivin expression does not alter MK/erythroid lineage development and that elevated survivin, alone, does not interfere with MK ploidy in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18245663      PMCID: PMC2288720          DOI: 10.1182/blood-2007-11-122150

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

Review 1.  Roads to polyploidy: the megakaryocyte example.

Authors:  Katya Ravid; Jun Lu; Jeffrey M Zimmet; Matthew R Jones
Journal:  J Cell Physiol       Date:  2002-01       Impact factor: 6.384

2.  Conditional overexpression of transgenes in megakaryocytes and platelets in vivo.

Authors:  Hao G Nguyen; Guangyao Yu; Maria Makitalo; Dan Yang; Hou-Xiang Xie; Matthew R Jones; Katya Ravid
Journal:  Blood       Date:  2005-05-12       Impact factor: 22.113

3.  Differential requirements for survivin in hematopoietic cell development.

Authors:  Sandeep Gurbuxani; Yanfei Xu; Ganesan Keerthivasan; Amittha Wickrema; John D Crispino
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-29       Impact factor: 11.205

4.  Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development.

Authors:  J E Visvader; Y Fujiwara; S H Orkin
Journal:  Genes Dev       Date:  1998-02-15       Impact factor: 11.361

5.  The mechanism underlying vascular smooth muscle cell apoptosis induced by atorvastatin may be mainly associated with down-regulation of survivin expression.

Authors:  Yi-Guan Xu; Sheng-Hua Zhou; Yu-Guang Li; Chun-Hua Zheng; Xu-Ping Li; Qi-Ming Liu; Duan-Min Xu; Shang Chen
Journal:  Cardiovasc Drugs Ther       Date:  2007-06       Impact factor: 3.727

6.  Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53.

Authors:  D Grossman; P J Kim; O P Blanc-Brude; D E Brash; S Tognin; P C Marchisio; D C Altieri
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

7.  Megakaryocytes express functional Aurora-B kinase in endomitosis.

Authors:  Amy E Geddis; Kenneth Kaushansky
Journal:  Blood       Date:  2004-05-06       Impact factor: 22.113

8.  Tel/Etv6 is an essential and selective regulator of adult hematopoietic stem cell survival.

Authors:  Hanno Hock; Eliza Meade; Sarah Medeiros; Jeffrey W Schindler; Peter J M Valk; Yuko Fujiwara; Stuart H Orkin
Journal:  Genes Dev       Date:  2004-09-15       Impact factor: 11.361

9.  Aberrant quantity and localization of Aurora-B/AIM-1 and survivin during megakaryocyte polyploidization and the consequences of Aurora-B/AIM-1-deregulated expression.

Authors:  Ying Zhang; Yuka Nagata; Guangyao Yu; Hao G Nguyen; Matthew R Jones; Paul Toselli; Carl W Jackson; Masaaki Tatsuka; Kazuo Todokoro; Katya Ravid
Journal:  Blood       Date:  2004-01-29       Impact factor: 22.113

10.  Requirements for survivin in terminal differentiation of erythroid cells and maintenance of hematopoietic stem and progenitor cells.

Authors:  Cindy G Leung; Yanfei Xu; Bretton Mularski; Hui Liu; Sandeep Gurbuxani; John D Crispino
Journal:  J Exp Med       Date:  2007-06-18       Impact factor: 14.307

View more
  6 in total

1.  New roles for cyclin E in megakaryocytic polyploidization.

Authors:  Alexia Eliades; Nikolaos Papadantonakis; Katya Ravid
Journal:  J Biol Chem       Date:  2010-04-14       Impact factor: 5.157

2.  Survivin localization during endomitosis of high ploidy mouse megakaryocytes.

Authors:  Donald J McCrann; Katya Ravid
Journal:  Blood       Date:  2010-09-23       Impact factor: 22.113

3.  Role of tumor suppressor p53 in megakaryopoiesis and platelet function.

Authors:  Pani A Apostolidis; Donna S Woulfe; Massiel Chavez; William M Miller; Eleftherios T Papoutsakis
Journal:  Exp Hematol       Date:  2011-10-21       Impact factor: 3.084

4.  Overexpression of survivin initiates hematologic malignancies in vivo.

Authors:  S Small; G Keerthivasan; Z Huang; S Gurbuxani; J D Crispino
Journal:  Leukemia       Date:  2010-09-30       Impact factor: 11.528

Review 5.  Targeted Diphtheria Toxin-Based Therapy: A Review Article.

Authors:  Fatemeh Shafiee; Marc G Aucoin; Ali Jahanian-Najafabadi
Journal:  Front Microbiol       Date:  2019-10-18       Impact factor: 5.640

6.  Use of a Novel Integrase-Deficient Lentivirus for Targeted Anti-Cancer Therapy With Survivin Promoter-Driven Diphtheria Toxin A.

Authors:  Baoshun Lin; Anding Gao; Rui Zhang; Hongyu Ma; Haifeng Shen; Qiong Hu; Hua Zhang; Meng Zhao; Xiaopeng Lan; Kuancan Liu
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.